Latest Licensing News

BLS Pharmaceuticals capped FY2026 with record quarterly revenue and operating cash flow, driven by international expansion and new supply agreements across regulated markets.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

Audeara Ltd posted record FY26 cash receipts of $4.2 million and unaudited revenue of $4.44 million, driven by progress in AI audio licensing, exclusive assistive listening deals, and a large-scale Auracast deployment across retirement villages.

Metallium has validated its Flash Joule Heating technology through extensive testing and multi-reactor operation, advancing towards commercial e-waste processing at its Texas campus in H1 2027.

Berkeley Energia has reported a maiden inferred lithium and rubidium resource at its Conchas Project in Spain, alongside appointing former Endesa CEO José Bogas Gálvez to its board, while continuing a US$1.25 billion arbitration against Spain over its Salamanca uranium project.

Streamplay Studio Limited has reported its fifth straight quarter of positive operating cash flow, driven by strong customer receipts and strategic publishing deals. The company is advancing multiple game releases and expanding its cloud gaming footprint across new regions.

Perseus Mining reported a robust June quarter with 109,013 ounces of gold produced at an AISC of US$1,941/oz, record FY26 cashflows of US$769 million, and Nyanzaga Gold Project 67% complete on track for January 2027 production.

Rand Mining’s cash balance fell to $2.086 million in June quarter as gold sales dipped and operating cash flow turned negative, pressured by higher production and development expenses.

Avecho Biotechnology has secured a unanimous recommendation to continue its Phase III insomnia trial without increasing sample size, alongside raising $1.9 million through option exercises and bolstering its cash position to $6.6 million.

Centaurus Metals has made significant strides towards a Final Investment Decision for its Jaguar Nickel Sulphide Project, securing strong debt financing interest, critical infrastructure approvals, and advancing engineering and pre-development works in Brazil.

AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.

Stelar Metals has secured environmental approval for its inaugural ~3,000m Reverse Circulation drilling campaign at the Hill of Leaders Tungsten Project, set to begin in August 2026. This marks the first deep drilling beneath a high-grade tungsten system with significant strike and width in the Northern Territory.